Total 61 patients , suffering from type II diabetes with fasting blood glucose ( FBG ) between 150 and 200mg/dL , glycated hemoglobin ( HbA1c ) between 7 % and 9 % and aged between 40 and 60 years were selected , and randomly divided in to two groups of Juglans regia and placebo .